UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
January 30, 2023 (January 30, 2023)
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
Delaware
|
1-644
|
13-1815595
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission
File Number)
|
(IRS Employer
Identification No.)
|
300 Park Avenue,
New York, New York |
10022
|
(Address of Principal Executive Offices) |
(Zip Code) |
Registrant’s telephone number, including area code (212) 310-2000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange
on which registered
|
Common Stock, $1.00 par value
|
|
CL
|
|
New York Stock Exchange
|
0.500% Notes due 2026
|
|
CL 26
|
|
New York Stock Exchange
|
0.300% Notes due 2029
|
|
CL 29
|
|
New York Stock Exchange
|
1.375% Notes due 2034
|
|
CL 34
|
|
New York Stock Exchange
|
0.875% Notes due 2039 |
|
CL 39 |
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule
12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On January 30, 2023, the Board of Directors (the “Board”) of Colgate-Palmolive Company (“Colgate”) elected Steven Cahillane, Chairman of the Board,
President and Chief Executive Officer of Kellogg Company (“Kellogg”), to the Colgate Board, effective February 1, 2023. Mr. Cahillane, 57, will bring extensive global business leadership experience and expertise in the consumer products and health
and nutrition industries to Colgate’s Board. Mr. Cahillane joined Kellogg, a global snacks, cereal and frozen foods company operating in more than 180 countries, as Chief Executive Officer in 2017 and became Chairman of the Board in 2018. Prior
to joining Kellogg, from 2014 to 2017, Mr. Cahillane served as President and Chief Executive Officer of The Nature’s Bounty Co. Mr. Cahillane previously spent seven years with The Coca-Cola Company culminating as Executive Vice President of The
Coca-Cola Company and President of Coca-Cola Americas. Prior to that, Mr. Cahillane served as President of various Coca-Cola operating groups. Mr. Cahillane will receive compensation as a non-employee director in accordance with Colgate’s director
compensation program described in Colgate’s proxy statement filed with the Securities and Exchange Commission on March 23, 2022.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
COLGATE-PALMOLIVE COMPANY |
|
|
|
|
|
|
|
|
Date: January 30, 2023
|
By:
|
/s/ Jennifer M. Daniels |
|
|
Name:
|
Jennifer M. Daniels |
|
|
Title:
|
Chief Legal Officer and Secretary |